The Lancet in conversation with
A podcast by The Lancet Group - Vineri
658 Episoade
-
Polypills Series: The Lancet: March 9, 2017
Publicat: 10.03.2017 -
Syndemics Series: The Lancet: March 2, 2017
Publicat: 03.03.2017 -
Crohn's disease: The Lancet: March 1, 2017
Publicat: 02.03.2017 -
2030 life expectancy estimates: The Lancet: February 21, 2017
Publicat: 22.02.2017 -
Religious leaders in promotion of male circumcision: The Lancet: February 14, 2017
Publicat: 15.02.2017 -
Type 2 diabetes: The Lancet: February 9, 2017
Publicat: 10.02.2017 -
Socioeconomic status as a risk factor for non-communicable diseases: The Lancet: January 31, 2017
Publicat: 01.02.2017 -
US premature mortality: The Lancet: January 25, 2017
Publicat: 26.01.2017 -
Pancreatic cancer: The Lancet: January 24, 2017
Publicat: 25.01.2017 -
Use of MRI in prostate cancer screening: The Lancet: January 19, 2017
Publicat: 20.01.2017 -
Amygdalar activity and cardiovascular events: The Lancet: January 12, 2017
Publicat: 13.01.2017 -
Right Care Series: The Lancet: January 8, 2017
Publicat: 09.01.2017 -
Ebola vaccine: The Lancet: December 22, 2016
Publicat: 23.12.2016 -
Wakley Prize 2016: The Lancet: December 15, 2016
Publicat: 16.12.2016 -
Breast Cancer 2016: The Lancet: December 6, 2016
Publicat: 07.12.2016 -
Phantom motor execution: The Lancet: December 1, 2016
Publicat: 01.12.2016 -
Multiple sclerosis Series: The Lancet: November 23, 2016
Publicat: 25.11.2016 -
Where next for US health and health care?
Publicat: 16.11.2016 -
The Lancet Countdown: The Lancet: November 13, 2016
Publicat: 14.11.2016 -
US Election reaction: The Lancet: November 11, 2016
Publicat: 11.11.2016
Jessamy Bagenal, Chloe Wilson, and Callum Davidson—editors at The Lancet—and Gavin Cleaver, The Lancet Group’s Audio Producer, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers topics that advance the field of medical research, from exploring treatments to examining drug trials, public health outbreaks to surgical techniques, and more.
